MedTrace Logo

Domestic Violence Intervention to Reduce Psychological Distress and Violence Among Women Experiencing IPV in Nepal

NCT05426863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 912

Last updated 2025-08-22

No results posted yet for this study

Summary

The aim of this study is to implement and evaluate the feasibility, acceptability, and effectiveness of a validated integrated multi-component intervention targeting secondary prevention of violence and addressing the mental health needs of women experiencing intimate partner violence.

Conditions

  • Intimate Partner Violence
  • Domestic Violence
  • Intervention
  • Mental Health
  • Secondary Prevention
  • Problem Management Plus
  • Cluster Randomized Trial

Interventions

BEHAVIORAL

DeVI

A multi-component intervention is devised from the components of PM+ developed by WHO incorporating the components of violence prevention. The intervention is anticipated to provide behavioral skills to the participants in the intervention arm which will enhance their coping skills with past experiences of violence, stress management skills, problem-solving skills and safety planning skills. Further, they will be shared the best practices and lessons learned which will aid in danger assessments and prevention of future violence. The intervention will be given to intervention arm in 5 different sessions, one in each week. The 1st session of the intervention is about understanding the multi-component intervention. The 2nd session is identifying and managing problem, 3rd session is about stress management, followed by development of safety plan in 4th session and last session is about promotion of social support.

Sponsors & Collaborators

  • Global and Sexual Health (GloSH)

    lead OTHER

Principal Investigators

  • Keshab Deuba, PhD · Karolinska Instituet

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2023-07-07
Completion
2024-02-22

Countries

  • Nepal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05426863 on ClinicalTrials.gov